Merck & Company, Inc. (MRK)

Healthcare

$145.60

+2.26%

nightly snapshot · 10/11/2026

ALPHASCORE™ · B · Watch

ALPHASCORE

62

/ 100

B

WATCH

▲ 0 · 30D

KEY FUNDAMENTALS

P/E115.6

ROE34.7%

NET MARGIN28.1%

GROSS MARGIN74.8%

MKT CAP$359.22B

loading full analysis…

DAILY BRIEF

Merck & Company, Inc. achieves an AlphaScore of 62/100 in the healthcare sector. Essential metrics show a high return on equity (roe) of 34.70% and a gross margin of 74.80%. A major strength is its favorable forward price-to-earnings (forwardPe) ratio of 15.62. Conversely, a primary risk is its exceptionally high trailing price-to-earnings (pe) ratio of 115.56.

Written 11/10/2026, 00:23:31 UTC · Snapshot 11/10/2026